From the Lab to the Emergency Department

The Benefit of High-sensitivity Troponin Testing in the U.S. Since 2017

Wednesday, August 7, 11:30 – 12:30 p.m.
Exhibit Hall, Theater 1
Supported by Roche Diagnostics


Nam Tran, PhD, and Sean Neath, MD, will share how high-sensitivity troponin T (hs-cTn T) improved chest pain assessment, emergency department efficiency, CMS quality measures, and resource utilization. A review of the current high sensitivity troponin options, including strategies for assessing risk and applying mitigation strategies, will also be presented.


Attendees will learn about:

  • Real-world experience going live with hs-cTn T at the University of California, Davis.
  • Understand the current hs-cTn T landscape and how to analyze risk and apply mitigation strategies.
  • Identify the impact hs-cTn can have on Emergency Department workflows, cost avoidance, and on CMS Quality Measures.


Julie Swain
Marketing Manager Cardiac and Critical Care
Roche Diagnostics
Indianapolis, IN


Nam Tran, PhD
Director of Chemistry and Toxicology
University of California, Davis
Davis, CA

Sean X. Neath, MD
University of California
San Diego, CA